Literature DB >> 21124241

The cumulative impact and associated costs of multiple health conditions on employee productivity.

Don Iverson1, Kate L Lewis, Peter Caputi, Sascha Knospe.   

Abstract

OBJECTIVE: This study investigates and provides comparative data on the relative contributions of multiple physical and psychological health conditions on work productivity.
METHODS: A total of 667 employees from the headquarters office of a multinational consumer goods manufacturing firm in Germany completed a purpose-designed self-report questionnaire addressing the presence of 13 common health conditions, and associated absenteeism and presenteeism. Adjustments for comorbidity and self-report bias were made using an innovative approach.
RESULTS: A total of 34.8% of participants experienced absenteeism and 78.4% experienced presenteeism for at least one health condition. The overall annualized productivity loss due to the 13 health conditions was more than 27 days, equating to 12.3% of employee capacity and about &OV0556;8.78 million for the 1298 persons employed at the site.
CONCLUSIONS: The combined effects of multiple health conditions on productivity account for a significant proportion of total employee costs.

Entities:  

Mesh:

Year:  2010        PMID: 21124241     DOI: 10.1097/JOM.0b013e3181fd276a

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  9 in total

1.  The effect of training on performance and health in middle age.

Authors:  D Leyk; A Sievert
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  Assessing the relationship between chronic health conditions and productivity loss trajectories.

Authors:  Elyssa Besen; Glenn Pranksy
Journal:  J Occup Environ Med       Date:  2014-12       Impact factor: 2.162

3.  Results From the Bipartisan Policy Center's CEO Council Physical Activity Challenge to American Business.

Authors:  Jeff Berko; Ron Z Goetzel; Enid Chung Roemer; Karen Kent; Janet Marchibroda
Journal:  J Occup Environ Med       Date:  2016-12       Impact factor: 2.162

4.  How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).

Authors:  Kathrin Krüger; Lara Marleen Fricke; Elise-Marie Dilger; Annett Thiele; Kristina Schaubert; Dyon Hoekstra; Fedor Heidenreich; Anna Levke Brütt; Jona T Stahmeyer; Alexander Stahmann; Anna-Lena Röper; Klaus-Peter Kubiak; Melissa Hemmerling; Anja Grau; Kerstin Eichstädt; Sabine Behrens; Christian Krauth
Journal:  PLoS One       Date:  2021-11-11       Impact factor: 3.240

Review 5.  Risk factors associated with respiratory infectious disease-related presenteeism: a rapid review.

Authors:  Sarah Daniels; Hua Wei; Yang Han; Heather Catt; David W Denning; Ian Hall; Martyn Regan; Arpana Verma; Carl A Whitfield; Martie van Tongeren
Journal:  BMC Public Health       Date:  2021-10-28       Impact factor: 3.295

6.  Changing concepts in approaches to occupational low back pain.

Authors:  Ko Matsudaira; Hiroyuki Oka; Takahiko Yoshimoto
Journal:  Ind Health       Date:  2022-04-15       Impact factor: 2.707

7.  Multiple chronic health conditions and their link with labour force participation and economic status.

Authors:  Deborah J Schofield; Emily J Callander; Rupendra N Shrestha; Megan E Passey; Richard Percival; Simon J Kelly
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

Review 8.  Multimorbidity and Its Impact on Workers: A Review of Longitudinal Studies.

Authors:  Giorgione G Cabral; Ana C Dantas de Souza; Isabelle R Barbosa; Javier Jerez-Roig; Dyego L B Souza
Journal:  Saf Health Work       Date:  2019-08-31

9.  The Economic Burden of Lost Productivity due to Presenteeism Caused by Health Conditions Among Workers in Japan.

Authors:  Takahiko Yoshimoto; Hiroyuki Oka; Tomoko Fujii; Tomohisa Nagata; Ko Matsudaira
Journal:  J Occup Environ Med       Date:  2020-10       Impact factor: 2.306

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.